insights_auto
Why is CSBR down 2.69%?
Dive Deeperchevron_right
CSBR:NASDAQ
Champions Oncology Inc
$4.47
arrow_downward
-2.69%(-0.12) 1D
Nov 19, 11:33:33 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
$4.47
High
$4.47
Low
$4.47
Mkt. cap
62.22M
Avg. vol.
6.90K
Volume
1.08K
52-wk high
$8.31
52-wk low
$4.41
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
Open
$4.47
High
$4.47
Low
$4.47
Mkt. cap
62.22M
Avg. vol.
6.90K
Volume
1.08K
52-wk high
$8.31
52-wk low
$4.41
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
News stories
From web sources and news partners
24/7 Wall St.
·
21 minutes ago
S&P 500 Drops Nearly 1% at Midday While the Dow Slides 1.5%
Investing.com
·
1 hour ago
Record-negative dealer gamma and what it means for the S&P 500
ChartMill
·
2 hours ago
S&P 500 Gap Movers: Today's Gap-Up and Gap-Down Stocks
Traders Union
·
21 minutes ago
Charlie Bilello: S&P 500 declines 8% from October peak, largest pullback since March
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, United States
SectorHealth Care
Industry-
Websitechampionsoncology.com